Hazardous waste : many enforcement actions do not meet EPA standards : report to congressional requesters /

"B-226799"--P. [1].

Superfund contracts : EPA's procedures for preventing conflicts of interest need strengthening: report to the Honorable John D. Dingell, Chairman, Subcommittee on Oversight and Investigations, Committee on Energy, House of Representatives /

"B-231219."--P. [1].

EPA-approved revisions to state implementation plans allowing increased sulfur dioxide emissions were legal : report to the chairman, Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /

"B-217221"--1st prelim. p.

Providing solutions for a better tomorrow : a progress report on U.S. EPA's drinking water treatment technology demonstrations in Ecuador, Mexico and China /

Shipping list no.: 99-0007-P

Managing for results : EPA's efforts to implement needed management systems and processes : report to Congressional requesters /

"B-276608"--P. 1.

EPA financial capability guidebook.

Cover title: Financial capability guidebook.

Proceedings of the 1986 EPA/APCA Symposium on Measurement of Toxic Air Pollutants /

"EPA Report No. 600/9-86-013"--P. ii.

Superfund : EPA has identified limited alterntives to incineration for cleaning up PCB and Dioxin contamination : report to Congressional requesters /

"B-266331"--P. 1.

Air pollution : EPA's strategy and resources may be inadequate to control air toxics : report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /

"B-236358.3"--P. [1]

Downregulation of muscle protein degradation in sepsis by eicosapentaenoic acid (EPA)

Eicosapentaenoic acid (EPA) has been shown to attenuate muscle atrophy in cancer, starvation and hyperthermia by downregulating the increased expression of the ubiquitin-proteasome proteolytic pathway leading to a reduction in protein degradation. In the current study EPA (0.5 g/kg) administered to septic mice completely attenuated the increased protein degradation in skeletal muscle by preventing the increase in both gene expression and protein concentration of the alpha- and beta-subunits of the 20S proteasome, as well as functional activity of the proteasome, as measured by the 'chymotrypsin-like' enzyme activity. These results suggest that muscle protein catabolism in sepsis is mediated by the same intracellular signalling pathways as found in other catabolic conditions.

Effect of eicosapentaenoic acid (EPA) on expression of a lipid mobilizing factor in adipose tissue in cancer cachexia

Adipose tissue of mice bearing a cachexia-inducing murine tumour (MAC16) shows increased expression of zinc-α2-glycoprotein (ZAG), a lipolytic factor thought to be responsible for the increased lipolysis. The anti-cachectic agent eicosapentaenoic acid (EPA) (0.5 g/kg) attenuated the loss of body weight in mice bearing the MAC16 tumour, and this was accompanied by downregulation of ZAG expression in both white and brown adipose tissue, as determined by Western blotting. Glucocorticoids may be responsible for the increased ZAG expression in adipose tissue. Dexamethasone (1.68 μM) stimulated lipolysis in 3T3-L1 adipocytes, and this effect was attenuated by EPA (50 μM). In addition the lipolytic action of dexamethasone was attenuated by anti-ZAG antibody, suggesting that the induction of lipolysis was mediated through an increase in ZAG expression. This was confirmed by Western blotting, which showed that dexamethasone (1.68 μM) induced a two-fold increase in ZAG expression in both cells and media, and that this was attenuated by EPA (50 μM). These results suggest that EPA may preserve adipose tissue in cachectic mice by downregulation of ZAG expression through interference with glucocorticoid signalling. © 2005 Elsevier Ltd. All rights reserved.

Procedimiento para la purificación de ácido eicosapentaenoico (EPA)

La presente invención se refiere a un procedimiento para la purificación de EPA mediante reacciones enzimáticas de esterificación, caracterizadas por lipasas, a partir de extractos de pescado y microalgas y al uso del factor adimensional de eficacia para la cuantificación de la eficacia de las lipasas para concentrar y recuperar de forma simultánea un ácido graso poliinsaturado en la fracción de ácidos grasos libres.

EPA Radon Risk Assessment Table for Smokers and Non-Smokers

This chart gives the long term effects of radon on smokers and non-smokers.

Comparison of emission rate values for odour and odorous chemicals derived from two sampling devices

Field and laboratory measurements identified a complex relationship between odour emission rates provided by the US EPA dynamic emission chamber and the University of New South Wales wind tunnel. Using a range of model compounds in an aqueous odour source, we demonstrate that emission rates derived from the wind tunnel and flux chamber are a function of the solubility of the materials being emitted, the concentrations of the materials within the liquid; and the aerodynamic conditions within the device – either velocity in the wind tunnel, or flushing rate for the flux chamber. The ratio of wind tunnel to flux chamber odour emission rates (OU m-2 s) ranged from about 60:1 to 112:1. The emission rates of the model odorants varied from about 40:1 to over 600:1. These results may provide, for the first time, a basis for the development of a model allowing an odour emission rate derived from either device to be used for odour dispersion modelling.